Cecilia Contardi

Dr. Cecilia Contardi

University of Pavia, Pavia, Italy
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ELErsilia De Lorenzi
Ersilia De Lorenzi
DFDavide Franceschini
Davide Franceschini
CCCecilia Contardi
Cecilia Contardi
RMRita Maria Concetta Di Martino
Rita Maria Concetta Di Martino
FSFrancesca Seghetti
Francesca Seghetti
Federica BellutiFederica Belluti
Federica Belluti
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that is not restricted to the neuronal compartment but includes important interactions with immune cells, including microglia. Protein aggregates, common pathological hallmarks of AD, bind to pattern recognition receptors on microglia and trigger an inflammatory response, which contributes to disease progression and severity. In this context, curcumin is emerging as a potential drug candidate able to affect multiple key pathways implicated in AD, including neuroinflammation. Therefore, we studied the effect of curcumin and its structurally related analogues cur6 and cur16 on amyloid-β (Aβ)-induced microglia activation and neuronal cell death, as well as their effect on the modulation of Aβ aggregation. Primary cortical microglia and neurons were exposed to two different populations of Aβ42 oligomers (Aβ42Os) where the oligomeric state had been assigned by capillary electrophoresis and ultrafiltration. When stimulated with high molecular weight Aβ42Os, microglia released proinflammatory cytokines that led to early neuronal cell death. The studied compounds exerted an anti-inflammatory effect on high molecular weight Aβ42O-stimulated microglia and possibly inhibited microglia-mediated neuronal cell toxicity. Furthermore, the tested compounds demonstrated antioligomeric activity during the process of in vitro Aβ42 aggregation. These findings could be investigated further and used for the optimization of multipotent candidate molecules for AD treatment

29 January 2024 in Analytical Chemistry
Verified
Journal Article
Closed access
CCCecilia Contardi
Cecilia Contardi
Davide RubesDavide Rubes
Davide Rubes
Massimo SerraMassimo Serra
Massimo Serra
Dorati RossellaDorati Rossella
Dorati Rossella
MDMarco Dattilo
Marco Dattilo
ELErsilia De Lorenzi
Ersilia De Lorenzi

25 July 2024 in Chemistry – A European Journal
Verified
Journal Article
Open access
CCCecilia Contardi
Cecilia Contardi
LMLiliia Mavliutova
Liliia Mavliutova
Massimo SerraMassimo Serra
Massimo Serra
Davide RubesDavide Rubes
Davide Rubes
Dorati RossellaDorati Rossella
Dorati Rossella
ELErsilia De Lorenzi
Ersilia De Lorenzi
We describe a facile method to prepare water‐compatible molecularly imprinted polymer nanogels (MIP NGs) as synthetic antibodies against target glycans. Three different phenylboronic acid (PBA) derivatives were explored as monomers for the synthesis of MIP NGs targeting either α2,6‐ or α2,3‐sialyllactose, taken as oversimplified models of cancer‐related sT and sTn antigens. Starting from commercially available 3‐acrylamidophenylboronic acid, also its 2‐substituted isomer and the 5‐acrylamido‐2‐hydroxymethyl cyclic PBA monoester derivative were initially evaluated by NMR studies. Then, a small library of MIP NGs imprinted with the α2,6‐linked template was synthesized and tested by mobility shift Affinity Capillary Electrophoresis (msACE), to rapidly assess an affinity ranking. Finally, the best monomer 2‐acrylamido PBA was selected for the synthesis of polymers targeting both sialyllactoses. The resulting MIP NGs display an affinity constant≈106 M−1 and selectivity towards imprinted glycans. This general procedure could be applied to any non‐modified carbohydrate template possessing a reducing end.